Dov Elefant
Fortune : 1 131 $ au 31/05/2026
Fortune : 1 131 $ au 31/05/2026
Dov S.
Elefant currently works at Femasys, Inc., as Chief Financial Officer from 2022.
Mr. Elefant also formerly worked at Tetragenex Pharmaceuticals, Inc., as Director-Accounting & Finance from 1999 to 2007, Synvista Therapeutics, Inc., as Assistant Controller from 1998 to 1999, Celsus Therapeutics Plc, as Chief Operating & Financial Officer from 2013 to 2015, Althera Medical Ltd., as Chief Financial Officer, Lev Pharmaceuticals, Inc., as Controller from 2007 to 2009, EpiCept Corp., as Controller, VP-Finance & Administration from 1999 to 2007, Cellectar Biosciences, Inc., as Chief Financial Officer & Vice President from 2019 to 2022, and Akari Therapeutics Plc, as Chief Financial Officer from 2012 to 2019.
Mr. Elefant received his undergraduate degree from Sy Syms School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 2 922 ( 0 % ) | 1 131 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FEMASYS INC. | Directeur Financier/CFO | 28/02/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Directeur Financier/CFO | 23/02/2022 |
| AKARI THERAPEUTICS, PLC | Directeur Financier/CFO | 15/09/2019 |
Althera Medical Ltd.
Althera Medical Ltd. Medical SpecialtiesHealth Technology Develops therapeutic devices for the treatment of various cancers | Directeur Financier/CFO | - |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases | Comptroller/Controller/Auditor | 01/02/2009 |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Directeur Financier/CFO | 01/03/2007 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Synvista Therapeutics, Inc.
Synvista Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases of cardiovascular aging and diabetes complications | Health Technology |
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Health Technology |
Femasys, Inc.
Femasys, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a medical device company that focuses on women''s healthcare | Electronic Technology |
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes antibiotics | Health Technology |
Althera Medical Ltd.
Althera Medical Ltd. Medical SpecialtiesHealth Technology Develops therapeutic devices for the treatment of various cancers | Health Technology |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic products for the treatment of inflammatory diseases | Health Technology |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
Sy Syms School of Business
Sy Syms School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national